http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105148279-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2015-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105148279-B |
| titleOfInvention | Dextran nano-medicament carrier and preparation method thereof and antineoplastic and preparation method thereof |
| abstract | The present invention relates to a kind of dextran nano-medicament carrier and preparation method thereof and antineoplastic and preparation method thereof.The dextran nano-medicament carrier includes the dextran nano-particle of carboxylated, and the particle diameter of the dextran nano-particle of the carboxylated is 20~100 nanometers.The carboxylated dextran nano-particle that particle diameter is 20~100 nanometers has good biological pardon and degradability, it can be used for carrying medicament and act on human body, and due to dextran the design feature of carboxylated in itself, hydrazone key carrying medicament can be passed through, hydrazone key is sensitive to pH, is broken and Targeting delivery medicine under specific pH environment.Therefore, above-mentioned dextran nano-medicament carrier can be used for the medicine-releasing system for establishing pH responses, to improve curative effect, reduce side effect. |
| priorityDate | 2015-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.